Cargando…
Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study
BACKGROUND: Hemodialysis patients are prone to constipation, which can adversely affect their quality of life (QOL). Elobixibat, a highly selective inhibitor of the ileal bile acid transporter, can increase the bile acid level in the colon and, subsequently, enhance colonic motility and secretion. I...
Autores principales: | Kamei, Daigo, Kamei, Yuiko, Nagano, Masashi, Mineshima, Michio, Nitta, Kosaku, Tsuchiya, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995167/ https://www.ncbi.nlm.nih.gov/pubmed/32005162 http://dx.doi.org/10.1186/s12876-020-1179-6 |
Ejemplares similares
-
Association between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients
por: Kamei, Yuiko, et al.
Publicado: (2018) -
Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation
por: Nakajima, Atsushi, et al.
Publicado: (2022) -
The Efficacy and Safety of Elobixibat for the Elderly with Chronic Constipation: A Multicenter Retrospective Cohort Study
por: Tomie, Akira, et al.
Publicado: (2020) -
Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake
por: Ozaki, Anna, et al.
Publicado: (2021) -
Efficacy and Safety of Elobixibat in Elderly Patients with Chronic Constipation: A Single-center, Observational Study
por: Abe, Tatsuya, et al.
Publicado: (2020)